A 47-year-old male patient was referred to our gastroenterology department, to investigate multiple and large conglomerate mediastinal adenopathies.
CASE REPORT
A 47-year-old male patient was referred to our gastroenterology department, to investigate multiple and large conglomerate mediastinal adenopathies.
He reported a 6-month history of anorexia, weight loss, hoarseness, decrease in visual acuity, and several pigmented skin nodules scattered over the whole body with an average size of 2 cm. More recently, he presented with diffuse abdominal pain, nausea and vomiting.
Upper endoscopy showed at the duodenal bulb and second part of duodenum, several sessile erythematous polyps, between 5 and 15 mm with central ulceration (Fig. 1) . The biopsy specimen revealed metastatic malignant melanoma. Immunohistochemistry stains showed neoplastic cells positive for S-100 protein (Fig. 2) .
Cutaneous investigation confirmed a very aggressive malignant melanoma (Fig. 3) , with disseminated metastasis, including intra-orbital, thyroid, bronchial, lymphatic, heart, pancreatic, peritoneal and bone metastasis.
Clinical management relied on symptomatic therapy only. Fig. 1 . Endoscopic image of the duodenal bulb and second part of duodenum: several sessile polyps with central depression. Malignant melanoma is the commonest tumour to metastasize to the gastrointestinal tract (GIT). Most frequent GIT metastasis includes the small bowel (50%), colon (31.3%) and anorectum (25%) (1) . Despite the frequent autopsy findings of GIT involvement by melanoma, the antemortem diagnosis is made only in 1.5 to 4.4% of all patients with melanoma (2).
PICTURES IN DIGESTIVE PATHOLOGY
The vast majority of GIT melanoma is metastatic from a cutaneous primary melanoma, although primary neoplasia can also arise from GIT (3).
Despite innocuous gastrointestinal symptoms, metastatic melanoma should be a diagnostic consideration in any patient with melanoma.
Prognosis of metastatic melanoma is extremely poor. Studies suggest a mean survival time of patients with systemic metastases from melanoma approximately 6 to 8 months (4, 5) .
